Effects of Soy Isoflavone and Endogenous Oestrogen on Breast Cancer in MMTV-erbB2 Transgenic Mice

Author： Zhang GP   Han D   Liu G   Gao SG   Cai XQ   Duan RH   Feng XS  

Publisher： Field House Publishing

ISSN： 0300-0605

Source： The Journal of International Medical Research, Vol.40, Iss.6, 2012-11, pp. : 2073-2082

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Anti-erbB-2 antibody trastuzumab in the treatment of HER2-amplified breast cancer

By Yeon Christina   Pegram Mark  

Investigational New Drugs, Vol. 23, Iss. 5, 2005-10 ,pp. : 391-409

Springer Publishing Company

Access to resources Recommend Favorite

Irreversible Multitargeted ErbB Family Inhibitors for Therapy of Lung and Breast Cancer

By  

Current Cancer Drug Targets, Vol. 14, Iss. 9, 2014-11 ,pp. : 775-793

Bentham Science Publishers

Access to resources Recommend Favorite

Expression of c-erbB-2 and p53 in Breast Carcinoma Patients: Comparison with Traditional Prognostic Factors and Survival

By Gurkan A   Erdogan G   Erdogan O   Pestereli E   Ogus M   Karaveli S   Colak T  

The Journal of International Medical Research, Vol. 32, Iss. 5, 2004-09 ,pp. : 455-464

Field House Publishing

Access to resources Recommend Favorite

ADAM proteases, ErbB pathways and cancer

By Zhou Bin-Bing S   Fridman Jordan S   Liu Xiangdong   Friedman Steve M   Newton Robert C   Scherle Peggy A  

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 6, 2005-06 ,pp. : 591-606

Informa Healthcare

Access to resources Recommend Favorite

The ErbB Receptors and their Ligands in Cancer: An Overview

By  

Current Drug Targets, Vol. 6, Iss. 3, 2005-05 ,pp. : 243-257

Bentham Science Publishers

Access to resources Recommend Favorite